Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies

Use of nicotine-specific monoclonal antibodies (mAbs) to sequester and reduce nicotine distribution to brain has been proposed as a therapeutic approach to treat nicotine addiction (the basis of tobacco use disorder). A series of monoclonal antibodies with high affinity for nicotine (nic•mAbs) was i...

Descripción completa

Detalles Bibliográficos
Autores principales: Raleigh, Michael D., Beltraminelli, Nicola, Fallot, Stephanie, LeSage, Mark G., Saykao, Amy, Pentel, Paul R., Fuller, Steve, Thisted, Thomas, Biesova, Zuzanna, Horrigan, Stephen, Sampey, Darryl, Zhou, Bin, Kalnik, Matthew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323890/
https://www.ncbi.nlm.nih.gov/pubmed/34329335
http://dx.doi.org/10.1371/journal.pone.0254247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323890/
https://www.ncbi.nlm.nih.gov/pubmed/34329335
http://dx.doi.org/10.1371/journal.pone.0254247

Ejemplares similares